Sunrakshakk Industries India Ltd (SUNRAKSHAK)
Plese find herewith press release regarding Financial Result Q2 H1 FY27 of the company
Press Release - Q2 FY27
- Revenue 265.17 Cr +119.20% y-y; EBITDA 23.14 Cr +98.26% y-y; PAT 16.00 Cr +130.10% y-y
- Consolidated revenue growth driven by FMCG, FMCG Intermediates, Textiles, and Edibles
- EBITDA margin at 8.73%, up 55 bps sequentially; YoY margin impacted by higher raw material costs
- PAT margin improved to 6.03% from 5.75% y-y and 5.44% q-q
- H1 FY27 revenue 541.50 Cr +119.93% y-y; PAT 31.04 Cr +130.39% y-y; EPS growth over 115%
- FMCG segments contributed over 90% of revenue with improved segment margins
- Capacity expansions at Guwahati and Roorkee increased FMCG production to 20,840 tonnes/month
- Company on track to exceed ₹1,000 Cr revenue target for FY28 ahead of schedule
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 SUNRAKSHAK — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add SUNRAKSHAK to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Sunrakshakk Industries India Ltd
Important.
The summary above is generated automatically from Sunrakshakk Industries India Ltd's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.